Altimmune (0A4C) Income Statement
Altimmune Income Statement
Last quarter (Q2 2026), Altimmune's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Altimmune's net income was $-22.82M. See Altimmune’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 41.00K | $ 20.00K | $ 426.00K | $ -68.00K | $ 4.41M | |
| $ 41.00K | $ 20.00K | $ 426.00K | $ -68.00K | $ 4.41M | |
| $ 94.53M | $ 103.19M | $ 96.36M | $ 87.67M | $ 101.32M | |
| Depreciation and Amortization | $ 112.00K | $ 238.00K | $ 477.00K | $ 493.00K | $ 551.00K |
| $ -87.03M | $ -94.81M | $ -87.94M | $ -84.41M | $ -96.53M | |
| $ -94.49M | $ -103.17M | $ -95.93M | $ -87.74M | $ -96.91M | |
| $ 5.71M | $ 8.11M | $ 7.48M | $ 2.83M | $ -176.00K | |
| $ -88.77M | $ -95.06M | $ -88.45M | $ -84.91M | $ -97.09M | |
| $ -88.09M | $ -95.06M | $ -88.45M | $ -84.71M | $ -97.09M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.00 | $ -1.34 | $ -1.66 | $ -1.81 | $ -2.35 |
| Diluted EPS | $ -1.00 | $ -1.34 | $ -1.66 | $ -1.81 | $ -2.35 |
| Weighted Average Shares Outstanding | 88.10M | 71.00M | 53.25M | 46.93M | 41.28M |
| Weighted Average Shares Outstanding (Diluted) | 88.10M | 71.00M | 53.25M | 46.93M | 41.28M |
Currency in USD
